Concepedia
1
Publications
27
Citations
H-Index
2022
Active since
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)
Chloë Hardern is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).
Publications per year
2022–2022
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States
Raquel Aguiar‐Ibáñez, Chloë Hardern, Frank van Hees et al. · Journal of Medical Economics · 2022 · 27 citations · Full text
Rows per page
1–1 of 1